Tilray, Inc. - Class 2 (TLRY): Price and Financial Metrics

Tilray, Inc. - Class 2 (TLRY)

Today's Latest Price: $18.60 USD

0.33 (-1.74%)

Updated Dec 13 12:00am

Add TLRY to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 214 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

TLRY Stock Summary

  • Tilray Inc's stock had its IPO on July 19, 2018, making it an older stock than merely 1.26% of US equities in our set.
  • With a price/sales ratio of 22.83, Tilray Inc has a higher such ratio than 95.41% of stocks in our set.
  • With a year-over-year growth in debt of 694.09%, Tilray Inc's debt growth rate surpasses 96.87% of about US stocks.
  • If you're looking for stocks that are quantitatively similar to Tilray Inc, a group of peers worth examining would be ADOM, TC, IMAX, KLXE, and UXIN.
  • Visit TLRY's SEC page to see the company's official filings. To visit the company's web site, go to www.tilray.com.
TLRY Daily Price Range
TLRY 52-Week Price Range

TLRY Stock Price Chart More Charts

TLRY Price/Volume Stats

Current price $18.60 52-week high $106.00
Prev. close $18.93 52-week low $18.00
Day low $18.50 Volume 1,474,500
Day high $19.45 Avg. volume 1,911,541
50-day MA $21.26 Dividend yield N/A
200-day MA $39.44 Market Cap 1.87B

Tilray, Inc. - Class 2 (TLRY) Company Bio

Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. was founded in 2018 and is based in Nanaimo, Canada.

TLRY Latest News Stream

Event/Time News Detail
Loading, please wait...

TLRY Latest Social Stream

Loading social stream, please wait...

View Full TLRY Social Stream

TLRY Price Returns

1-mo -6.67%
3-mo -39.59%
6-mo -54.69%
1-year -75.24%
3-year N/A
5-year N/A
YTD -73.63%
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.486 seconds.